Kyoko Soejima

Kyoko Soejima

Auto-generated profile, based on publicly available information

Kyoko Soejima

Department of Cardiovascular Medicine, Kyorin University School of Medicine, Mitaka, Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
JCJames Coromilas
James Coromilas
SKStephanie Kochav
Stephanie Kochav
IGIsaac Goldenthal
Isaac Goldenthal
ABAngelo Biviano
Angelo Biviano
HGHasan Garan
Hasan Garan
EWElaine Y. Wan
Elaine Y. Wan
Background - COVID-19 has led to over 1 million deaths worldwide and has been associated with cardiac complications including cardiac arrhythmias. The incidence and pathophysiology of these manifestations remain elusive. In this worldwide survey of patients hospitalized with COVID-19 who developed cardiac arrhythmias, we describe clinical characteristics associated with various arrhythmias, as well as global differences in modulations of routine electrophysiology practice during the pandemic. Methods - We conducted a retrospective analysis of patients hospitalized with COVID-19 infection worldwide with and without incident cardiac arrhythmias. Patients with documented atrial fibrillation (AF), atrial flutter (AFL), supraventricular tachycardia (SVT), non-sustained or sustained ventricular tachycardia (VT), ventricular fibrillation (VF), atrioventricular block (AVB), or marked sinus bradycardia (HR<40bpm) were classified as having arrhythmia. De-identified data was provided by each institution and analyzed. Results - Data was collected for 4,526 patients across 4 continents and 12 countries, 827 of whom had an arrhythmia. Cardiac comorbidities were common in patients with arrhythmia: 69% had hypertension, 42% diabetes mellitus, 30% had heart failure and 24% coronary artery disease. Most had no prior history of arrhythmia. Of those who did develop an arrhythmia, the majority (81.8%) developed atrial arrhythmias, 20.7% developed ventricular arrhythmias, and 22.6% had bradyarrhythmia. Regional differences suggested a lower incidence of AF in Asia compared to other continents (34% vs. 63%). Most patients in in North America and Europe received hydroxychloroquine, though the frequency of hydroxychloroquine therapy was constant across arrhythmia types. Forty-three percent of patients who developed arrhythmia were mechanically ventilated and 51% survived to hospital discharge. Many institutions reported drastic decreases in electrophysiology procedures performed. Conclusions - Cardiac arrhythmias are common and associated with high morbidity and mortality among patients hospitalized with COVID-19 infection. There were significant regional variations in the types of arrhythmias and treatment approaches.

28 January 2019 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
PDF file
MEMikhael F El-Chami
Mikhael F El-Chami
JJJens Brock Johansen
Jens Brock Johansen
AZAmir Zaidi
Amir Zaidi
SFSvein Faerestrand
Svein Faerestrand
DRDwight Reynolds
Dwight Reynolds
JPJonathan P. Piccini
Jonathan P. Piccini
Introduction: Leadless pacemakers may provide a safe and attractive pacing option to patients with cardiac implantable electronic device (CIED) infection. We describe the characteristics and outcomes of patients with a recent CIED infection undergoing Micra implant attempt.Methods and Results: Patients with prior CIED infection and device explant with Micra implant within 30 days, were identified from the Micra post approval registry. Procedure characteristics and outcomes were summarized. A total of 105 patients with prior CIED infection underwent Micra implant attempt ≤30 days from prior system explant (84 [80%] pacemakers and 13 [12%] ICD/CRT‐D). All system components were explanted in 93% of patients and explant occurred a median of 6 days before Micra implant, with 37% occurring on the day of Micra implant. Micra was successfully implanted in 99% patients, mean follow‐up duration was 8.5 ± 7.1 months (range 0‐28.5). The majority of patients (91%) received IV antibiotics preimplant, while 42% of patients received IV antibiotics postprocedure. The median length of hospitalization following Micra implant was 2 days (IQR, 1‐7). During follow‐up, two patients died from sepsis and four patients required system upgrade, of which two patients received Micra to provide temporary pacing support. There were no Micra devices explanted due to infection.Conclusion: Implantation of the Micra transcatheter pacemaker is safe and feasible in patients with a recent CIED infection. No recurrent infections that required Micra device removal were seen. Leadless pacemakers appear to be a safe pacing alternative for patients with CIED infection who undergo extraction.

29 June 2016 in Heart Rhythm
Verified
Journal Article
Closed access
PDF file
KSKyoko Soejima
Kyoko Soejima
JEJonathan Edmonson
Jonathan Edmonson
MEMichael L. Ellingson
Michael L. Ellingson
BHBen Herberg
Ben Herberg
CWCraig Wiklund
Craig Wiklund
JZJing Zhao
Jing Zhao

7 January 2022 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
ANAkihiko Nogami
Akihiko Nogami
TKTakashi Kurita
Takashi Kurita
KKKengo Kusano
Kengo Kusano
MGMasahiko Goya
Masahiko Goya
MSMorio Shoda
Morio Shoda
TGthe Japanese Circulation Society / the Japanese Heart Rhythm Society Joint Working Group
the Japanese Circulation Society / the Japanese Heart Rhythm Society Joint Working Group
Click on the article title to read more.

13 June 2011 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
ITIkuko Togashi
Ikuko Togashi
TSToshiaki Sato
Toshiaki Sato
KSKyoko Soejima
Kyoko Soejima
STSeiji Takatsuki
Seiji Takatsuki
SMShunichiro Miyoshi
Shunichiro Miyoshi
KFKeiichi Fukuda
Keiichi Fukuda

1 October 2021 in JACC: Clinical Electrophysiology
Verified
Journal Article
Open access
NNNoriko Matsushita Nonoguchi
Noriko Matsushita Nonoguchi
MAMasamitsu Adachi
Masamitsu Adachi
ANAkihiko Nogami
Akihiko Nogami
YKYuki Komatsu
Yuki Komatsu
TSToshiaki Sato
Toshiaki Sato
KSKyoko Soejima
Kyoko Soejima
This study investigates the effect of stellate ganglion (SG) phototherapy in healthy participants and assesses its efficacy in suppressing electrical storm (ES) refractory to antiarrhythmic drugs and catheter ablation. Modulation of the autonomic nervous system has been shown to be an effective adjunctive therapy for ES. Ten-minute SG phototherapy was performed twice weekly for 4 weeks in 20 healthy volunteers. To evaluate the acute and chronic effects of SG phototherapy, heart rate variability and serum concentrations of adrenaline, noradrenaline, and dopamine were obtained before phototherapy, immediately after the first phototherapy session, after 8 sessions of phototherapy, and 3 months after the first phototherapy session. In addition, the efficacy of SG phototherapy was evaluated in 11 patients with ES refractory to medication, sedation, and catheter ablation. In healthy participants, serum adrenaline concentration significantly decreased after phototherapy, whereas low-frequency power/high-frequency power significantly decreased during phototherapy. Moreover, the effect on heart rate variability did not last beyond 3 months. In the clinical pilot study, 7 patients had a suppression of ES after SG phototherapy; however, without maintenance therapy, 2 patients had a recurrence of ventricular arrhythmias. Furthermore, it did not control ES in 4 patients. SG phototherapy reduced sympathetic activity and may be a safe and effective adjunctive therapy to control ES in some patients, but its long-term efficacy remains unknown. Chronic phototherapy might help reduce ES recurrence.